Literature DB >> 3510168

Molecular specificities of monoclonal antibodies directed against virulent Treponema pallidum.

K S Marchitto, C K Selland-Grossling, M V Norgard.   

Abstract

Radioimmunoprecipitation (RIP) and Western blot analyses with specific anti-Treponema pallidum subsp. pallidum monoclonal antibodies were used to identify antigens with apparent masses of 102, 84, 54, 53, 52, 47, 32, 29, and 24 kilodaltons (kDa). Cross-reactivity of these antibodies with T. pallidum subsp. pertenue antigens and lack of cross-reactivity with T. phagedenis biotype Reiter, T. vincentii, T. refringens, T. scoliodontum, and T. denticola were also demonstrated by RIP and Western blot analyses. Reactivities in the T. pallidum immobilization test, along with the RIP of lactoperoxidase-catalyzed iodination products, suggested that the identified antigens were surface associated. The abundance and surface association of the 47- and 84-kDa antigens were supported by reactivity in the microhemagglutination test for T. pallidum and by strong reactivity of monoclonal antibodies upon indirect immunofluorescence assays with rabbit-cultivated T. pallidum subsp. pallidum, respectively, but not with T. phagedenis biotype Reiter. Anti-47-kDa and anti-84-kDa monoclonal antibodies were also reactive in indirect immunofluorescence assays using treponemes found in dark-field-positive smears of human genital ulcers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510168      PMCID: PMC261081          DOI: 10.1128/iai.51.1.168-176.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Value and limitations of nontreponemal and treponemal tests in the laboratory diagnosis of syphilis.

Authors:  J N Miller
Journal:  Clin Obstet Gynecol       Date:  1975-03       Impact factor: 2.190

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Molecular characterization of common treponemal antigens.

Authors:  P A Hanff; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

5.  Purification of Treponema pallidum, Nichols strain, by Percoll density gradient centrifugation.

Authors:  P A Hanff; S J Norris; M A Lovett; J N Miller
Journal:  Sex Transm Dis       Date:  1984 Oct-Dec       Impact factor: 2.830

6.  Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.

Authors:  S A Lukehart; S A Baker-Zander; E R Gubish
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

7.  Quantitative microhaemagglutination assay for Treponema pallidum antibodies in experimental syphilis.

Authors:  R R Tight; A C White
Journal:  Br J Vener Dis       Date:  1980-10

8.  Surface characterization of virulent Treponema pallidum.

Authors:  J F Alderete; J B Baseman
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

9.  Characterization of monoclonal antibodies to Treponema pallidum.

Authors:  S A Lukehart; M R Tam; J Hom; S A Baker-Zander; K K Holmes; R C Nowinski
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

10.  Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum.

Authors:  J B Baseman; E C Hayes
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  14 in total

Review 1.  The endemic treponematoses.

Authors:  Lorenzo Giacani; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

2.  Cloning and expression of the major 47-kilodalton surface immunogen of Treponema pallidum in Escherichia coli.

Authors:  M V Norgard; N R Chamberlain; M A Swancutt; M S Goldberg
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

3.  Major integral membrane protein immunogens of Treponema pallidum are proteolipids.

Authors:  N R Chamberlain; M E Brandt; A L Erwin; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Acylation of the 47-kilodalton major membrane immunogen of Treponema pallidum determines its hydrophobicity.

Authors:  N R Chamberlain; L DeOgny; C Slaughter; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  The 47-kDa major lipoprotein immunogen of Treponema pallidum is a penicillin-binding protein with carboxypeptidase activity.

Authors:  L M Weigel; J D Radolf; M V Norgard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Changes in the cell surface properties of Treponema pallidum that occur during in vitro incubation of freshly extracted organisms.

Authors:  L V Stamm; R L Hodinka; P B Wyrick; P J Bassford
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Specific immunofluorescent staining of pathogenic treponemes with a monoclonal antibody.

Authors:  F Ito; E F Hunter; R W George; V Pope; S A Larsen
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

8.  Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum.

Authors:  L M Weigel; M E Brandt; M V Norgard
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Genetic and physicochemical characterization of the recombinant DNA-derived 47-kilodalton surface immunogen of Treponema pallidum subsp. pallidum.

Authors:  N R Chamberlain; J D Radolf; P L Hsu; S Sell; M V Norgard
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

10.  Sequence analysis of the 47-kilodalton major integral membrane immunogen of Treponema pallidum.

Authors:  P L Hsu; N R Chamberlain; K Orth; C R Moomaw; L Q Zhang; C A Slaughter; J D Radolf; S Sell; M V Norgard
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.